Pfizer, Lilly, AstraZeneca Giving NIH Abandoned Drugs

Pharma giants Pfizer, Eli Lily, and AstraZeneca plan to give more than 20 abandoned drugs to the NIH, who in turn will provide the drugs and over 20 million in funding to academic researchers with viable proposals for repurposing these dugs for new indications. Are any potential ALS drugs hiding among them?

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail